Abstract
ASSESSMENT OF VACCINATION STATUS, CLINICAL MANIFESTATION, COMORBIDITIES AND MORTALITY STATUS RATE OF COVID 19 PATIENTS DURING 2nd WAVE- A PROSPECTIVE CROSS-SECTIONAL STUDY

Dr. Lakshmi Sabapathi, Dr. Vasanth S., Aravind Raj J.*, Nantha Kumar K. and Madhan C.

ABSTRACT

Background: We collected data from patients with COVID-19 confirmed between May 25 and July 31, 2021. This was a cross-sectional study conducted by tele-consultation with a sample size of 306 patients. By interacting with patients via questionnaires used to gather required information and analyzed. Materials and Methods: We collected data from patients with COVID-19 confirmed between May 25 and July 31, 2021. This was a cross-sectional study conducted by tele-consultation with a sample size of 306 patients. By interacting with patients via questionnaires used to gather required information and analyzed. Results: Among 306 patients (53.6%) were male and (46.4%) female seen at common age group of 40 -70 years in age. About 76.4% of patients who not get at least single dose of vaccination and Maximum patient’s not had any co-morbidity (64.4%) and others associated with diabetic (19.9%), blood pressure (14.7%), heart problem (5.8%), thyroid (4.8%), and others (9.2%).65% of people had fatigue, (21.9%) increased appetite, (16.8%) cough. We found there is no clear reports of modes of transmission other than family clusters. Conclusion: The study suggests that Although the age range of confirmed cases of COVID-19 almost all age groups, most patients with confirmed COVID-19 tend to be middle age persons. The patients with co-morbidity have more risks outcomes compared with patients without co-morbid condition. Vaccination was helps in reducing the mortality rate and home quarantine may help in preventing further transmission. Family cluster was the most common suspected mode of transmission.

Keywords: COVID-19, Comorbidity, Quarantine, Transmission, Vaccination.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2022 Issue has been successfully launched on 1 NOVEMBER 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT